Snapshots Saudi Arabia Pharmaceuticals 2010


October 27, 2010
15 Pages - SKU: SNAP2847449
License type:
Countries covered: Saudi Arabia

Snapdata's Snapshots Saudi Arabia Pharmaceuticals 2010 provides 2009 year-end market size data, with 2010 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the Saudi Arabian pharmaceutical market and covers imported drugs and domestic produced drugs.Market value is based on retail sales. The data is supplied in both graphical and tabular format for ease of interpretation and analysis.The Snapshots Saudi Arabia Pharmaceuticals 2010 forms part of Snapdata's Pharmaceuticals industry coverage.


Additional Information

Scope
  • Market Size by Value
  • Market Segmentation
  • Market Segmentation by Value
  • Market Shares
  • Market Shares by Value
  • Market Forecast
  • Market Forecast by Value
Company
  • Spimaco
  • GlaxoSmithKline
  • Pfizer
  • Tabuk
  • Jamjoom Pharma
  • Julphar
  • Novartis
  • Glaxo Saudi Arabia
  • AstraZeneca
  • Bayer Schering PH

More Prescription Drugs reports by Mintel - Snapshots

Pharmaceuticals – Czech Republic – a snapshot (2011) by Mintel - Snapshots
Pharmaceuticals in Czech Republic by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2011. This market covers ...
Pharmaceuticals – Slovak Republic – a snapshot (2011) by Mintel - Snapshots
Pharmaceuticals in Slovak Republic by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2011. This market covers ...
Pharmaceuticals – US – a snapshot (2011) by Mintel - Snapshots
Pharmaceuticals in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2011. This market covers prescription ...
Pharmaceuticals – Venezuela – a snapshot (2011) by Mintel - Snapshots
Pharmaceuticals in Venezuela by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2011. This market covers prescription ...
See all reports like this >>

More Saudi Arabia Prescription Drugs reports

Saudi Arabia Pharmaceuticals and Healthcare Report Q2 2013 by Business Monitor International
BMI View: Favourable demographic and epidemiological trends and the expansion of the country’shealthcare services will continue to underpin the development of Saudi Arabia\s pharmaceutical marketvalues. ...
Calming and Sleeping in Saudi Arabia by Euromonitor International
The government did little to prevent UTC sales of Rx medicines in most product areas during the review period, with most chemists/pharmacies selling Rx products ...
Saudi Arabia Pharmaceuticals and Healthcare Report Q4 2012 by Business Monitor International
BMI View: Saudi Arabia’s transition to an increasingly privatised and comprehensive healthcare systemwill drive the demand for both patented and generic drugs. The country is ...
Saudi Arabia Pharmaceuticals and Healthcare Report Q3 2012 by Business Monitor International
BMI View: The Saudi Arabian government said it will increase its healthcare budget for 2012 by 26%. Though BMI remains slightly more conservative in ...
See all reports like this >>

More Saudi Arabia reports

D&B Country RiskLine Report: Saudi Arabia by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
2007 Saudi Arabia Industry & Market Outlook by Barnes Reports
The 2007 Saudi Arabia Industry & Market Outlook report is the leading annual publication that describes over 100 major industries in Saudi Arabia and 500+ ...
See all reports like this >>

 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!